Table 3.
Platelet indices calculated from peripheral blood morphology in RVO patients and controls.
| Parameter | RVO (n = 35) | CRVO (n = 21) | BRVO (n = 13) | Controls (n = 35) |
|---|---|---|---|---|
| PLT (×103) [cells/µL] | 210 (185; 250) | 225 (196; 286) | 203 (185; 209) | 236 (182; 261) |
| MPV [fl] | 11.2 (10.5; 11.7) | 11.3 (10.8; 11.7) | 10.8 (10.3; 11.7) | 10.7 (10.1; 11.9) |
| PCT (%) | 0.24 (0.20; 0.28) | 0.25 (0.20; 0.30) | 0.22 (0.20; 0.23) | 0.25 (0.21; 0.27) |
| PDW (fl) | 13.1 (12.1; 15.2) | 13.9 (12.5; 15.3) | 12.6 (12.1; 15.2) | 12.5 (12.0; 13.4) |
| Reticulated platelets (×103) [cells/µL] | 0.074 (0.052; 0.088) | 0.077 (0.060; 0.088) | 0.066 (0.05; 0.088) | 0.066 (0.056; 0.084) |
Data are presented as median and interquartile: Me (Q1; Q3). No statistically significant differences vs. controls were found. Significance of differences between RVO and control group was estimated using the Mann–Whitney U non-parametric test. Significance of differences between BRVO vs. controls and CRVO vs. controls was estimated using the Kruskal–Wallis non-parametric test with Dunn’s multiple comparison test. PLT—platelet count, MPV—Mean Platelet Volume, PCT—plateletcrit, PDW—Platelet Distribution Width. BRVO—Branch Retinal Vein Occlusion, CRVO—Central Retinal Vein Occlusion, RVO—Retinal Vein Occlusion.